Skip to content

Role of Obstructive Sleep Apnea in Stroke Appearance

Role of Nocturnal Respiratory Disorders on Ischemic Stroke Occurrence

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00613522
Acronym
AVSAS
Enrollment
289
Registered
2008-02-13
Start date
2007-11-30
Completion date
2014-12-31
Last updated
2015-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea, Stroke

Keywords

Sleep apnea, Berlin, Stroke

Brief summary

Stroke is the third leading cause of death in industrialized countries and the first cause of handicap in adults. Several stroke risk factors were identified such as high blood pressure, diabetes mellitus, hypercholesterolemia or cardiac arrhythmias. Sleep respiratory disorders have been found to be frequent among patients with stroke. Among them obstructive sleep apnea (OSA) syndrome seems to be the most important due to its association with high blood pressure and atrial fibrillation. Stroke can be responsible of central apneas, therefore the differential diagnosis between central apneas and pure OSA after stroke is sometimes difficult. The misidentification of OSA can explain the poor tolerance of CPAP treatment by these patients. The purpose of the present study is to investigate the association between pre-stroke OSA syndrome OSA diagnosed on specific scales and confirmed by polygraphic studies and stroke occurrence.

Detailed description

• Principal Objective : Investigate the association between obstructive sleep apnea diagnosed and hemispheric ischemic stroke • Secondary Objective : Evaluate the relation between obstructive sleep apnea and: * stroke mechanisms * stroke prognosis * post-stroke tolerance to CPAP treatment. * Study design : Prospective case-control study • Inclusion criteria : Patients (150): Fist ischaemic hemispheric stroke or TIA Age: 50 to 90 French native speaker Able to answer the questions Controls (600): Age: 50 to 90 French native speaker Able to answer the questions • Exclusion criteria : Patients Haemorrhagic stroke Stroke of the brainstem Past medical history of ischaemic stroke Dementia Confusion Unable to give his informed consent Controls: Past medical history of ischaemic stroke Dementia Confusion Unable to give his informed consent • Study plan: Cases will be recruited in the stroke unit of the Pr Orgogozo at the Bordeaux University hospital. After verification of inclusion and exclusion criteria Berlin scale will be measured. A polygraphic study will be performed to patients with a Berlin scale \> 2. Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome). Controls will be recruited among sex and age matched patients hospitalized at the Bordeaux-University hospital for investigation of non-vascular disorder. After verification of inclusion and exclusion criteria Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale \> 2. Controls will be evaluated at 3 months using a phone interview • Number of subjects : 150 cases and 600 controls

Interventions

OTHERpolygraphic study

Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale \> 2. Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome). Controls will be evaluated at 3 months using a phone interview

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

(patients) : * Fist ischaemic hemispheric stroke or TIA * Age: 50 to 90 * French native speaker * Able to answer the questions Inclusion criteria (Controls): * Age: 50 to 90 * French native speaker * Able to answer the questions

Exclusion criteria

(patients): * Haemorrhagic stroke * Stroke of the brainstem * Past medical history of ischaemic stroke * Dementia * Confusion * Unable to give his informed consent

Design outcomes

Primary

MeasureTime frame
Stroke recurrence3 months

Secondary

MeasureTime frame
Stroke outcome (Rankin, Barthel) Stroke mechanism CPAP tolerance3 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026